Cross-protection in nonhuman primates against Argentine hemorrhagic fever.
The susceptibility of the marmoset Callithrix jacchus to Tacaribe virus infection was investigated to perform cross-protection studies between Junin and Tacaribe viruses. Five marmosets inoculated with Tacaribe virus failed to show any signs of disease, any alterations in erythrocyte, leukocyte, reticulocyte, and platelet counts or any changes in hematocrit or hemoglobin values. No Tacaribe virus could be recovered from blood at any time postinfection. Anti-Tacaribe neutralizing antibodies appeared 3 weeks postinfection. The five Tacaribe-infected marmosets and four noninfected controls were challenged with the pathogenic strain of Junin virus on day 60 post-Tacaribe infection. The former group showed no signs of disease, no viremia, and no challenge virus replication, whereas the control group exhibited the typical symptoms of Argentine hemorrhagic fever, high viremia, and viral titers in organs. Soon after challenge, the Tacaribe-protected marmosets synthesized neutralizing antibodies against Junin virus. These results indicate that the marmoset C. jacchus can be considered an experimental model for protection studies with arenaviruses and that the Tacaribe virus could be considered as a potential vaccine against Junin virus.
D000818:Animals; D000914:Antibodies, Viral / Q000032:analysis; D001116:Arenaviridae / Q000276:immunology*; D006477:Arenaviruses, New World / Q000254:growth & development / Q000276:immunology*; D001772:Blood Cell Count; D002144:Callithrix; D003429:Cross Reactions; D006400:Hematocrit; D006478:Hemorrhagic Fever, American / Q000097:blood / Q000276:immunology*; D014766:Viremia
D000914:Antibodies, Viral